Glaxo Sues XenoPort Over Contract for Restless-Leg Medicine

A GlaxoSmithKline Plc unit sued XenoPort Inc. in federal court in Delaware, seeking a ruling that it properly promoted the restless-leg medicine Horizant in the U.S.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.